Bioscience Biotechnology Research Communications

An International  Peer Reviewed Refereed Open Access Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Sanskruti. A. Patil1, Nandkishor Bankar2 and Manju Chandankhede3

1Bhagat Datta Meghe Medical College,Shalinitai Meghe Hospital and Research Centre, Nagpur, India.

2Department of Microbiology Jawaharlal Nehru Medical College, Datta Meghe
Institute of Medical Sciences Sawangi (Meghe), Wardha

3HOD Department of Biochemistry Datta Meghe Medical College, Shalinitai
Meghe Hospital and Research Centre, Nagpur, India.

Article Publishing History

Received: 28/03/2021

Accepted After Revision: 29/05/2021

ABSTRACT:

On 2019 December, the first COVID-19 patient was detected in Wuhan, China.Currently, the world is still facing the pandemic. The novel virusis associatedwith pneumonia. Coronaviruses are RNA single-stranded viruses. They are enveloped. This notorious virus isclassified into: alpha (cause asymptomatic infections), beta,gamma and delta coronaviruses (subfamilies). The doctors use corticosteroids and antibiotics to reduce inflammation of various secondary bacterial infections. Mesenchymal stem cell (MSCs) can be used in the treatment of this virus because of their multipotent characteristic as well as their characteristic plasticity . In this paper we try to analyse the treatment for covid-19 with the help of characteristic feature of plasticity of stem cells including its multipotent character. The reason for this article is to survey the proof for the alternative treatment of SARS CoV -2 with the help of stem cell based theory.

KEYWORDS:

Stem cell, COVID-19, MSCs,SARS CoV-2.

Download this article as:

Copy the following to cite this article:


Copy the following to cite this URL: